Skip to main content
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma
Published Web Location
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057142/pdf/nou029.pdfNo data is associated with this publication.